• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

俄罗斯成年人群感染率:系统评价与荟萃分析

The Prevalence of Infection in the Adult Population of Russia: A Systematic Review and Meta-Analysis.

作者信息

Andreev Dmitrii N, Khurmatullina Alsu R, Maev Igor V, Bordin Dmitry S, Abdulkhakov Sayar R, Kucheryavyy Yury A, Beliy Petr A, Sokolov Filipp S

机构信息

Department of Internal Disease Propaedeutics and Gastroenterology, Russian University of Medicine, 127473 Moscow, Russia.

Department of Pancreatic, Biliary and Upper Digestive Tract Disorders, A. S. Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.

出版信息

Epidemiologia (Basel). 2025 Aug 12;6(3):47. doi: 10.3390/epidemiologia6030047.

DOI:10.3390/epidemiologia6030047
PMID:40843706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12372033/
Abstract

The objective of this study is to assess the dynamics of infection prevalence among adults in Russia. A systematic search was conducted in MEDLINE/PubMed, EMBASE, Cochrane, RSCI, and Google Scholar for studies published between 1985 and 27 February 2025, following PRISMA guidelines. The meta-analysis was registered in PROSPERO (CRD420251011643). Twenty studies were included (n = 117,841; weighted mean age: 43.71 ± 16.23 years), all using validated diagnostic methods. The pooled prevalence from 1994 to 2024 was 62.847% (95% CI: 55.101-70.274), including 45.143% (95% CI: 41.390-48.923) by the C-urea breath test and 75.806% (95% CI: 64.213-85.742) by serology. Prevalence declined over time: it was 79.334% before 2005, 74.074% in 2006-2011, and 66.319% in 2012-2017, and it has been 42.949% since 2018. Meta-regression confirmed a significant decrease (coefficient: -3.773% per year, < 0.001). A significant decline in the prevalence of has been observed, however, it remains relatively high and requires continued efforts aimed at diagnosis and eradication.

摘要

本研究的目的是评估俄罗斯成年人感染率的动态变化。按照PRISMA指南,在MEDLINE/PubMed、EMBASE、Cochrane、RSCI和谷歌学术中对1985年至2025年2月27日发表的研究进行了系统检索。该荟萃分析已在PROSPERO(CRD420251011643)中注册。纳入了20项研究(n = 117,841;加权平均年龄:43.71 ± 16.23岁),所有研究均使用经过验证的诊断方法。1994年至2024年的合并感染率为62.847%(95%置信区间:55.101 - 70.274),其中碳-尿素呼气试验检测的感染率为45.143%(95%置信区间:41.390 - 48.923),血清学检测的感染率为75.806%(95%置信区间:64.213 - 85.742)。感染率随时间下降:2005年前为79.334%,2006 - 2011年为74.074%,2012 - 2017年为66.319%,自2018年以来为42.949%。荟萃回归证实感染率显著下降(系数:每年-3.773%,< 0.001)。已观察到感染率显著下降,然而,其仍相对较高,需要继续努力进行诊断和根除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/c3a3bf6bd11d/epidemiologia-06-00047-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/efbbc19adb24/epidemiologia-06-00047-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/16d5f28def5c/epidemiologia-06-00047-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/33374bae1b19/epidemiologia-06-00047-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/049037a16409/epidemiologia-06-00047-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/c3a3bf6bd11d/epidemiologia-06-00047-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/efbbc19adb24/epidemiologia-06-00047-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/16d5f28def5c/epidemiologia-06-00047-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/33374bae1b19/epidemiologia-06-00047-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/049037a16409/epidemiologia-06-00047-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/12372033/c3a3bf6bd11d/epidemiologia-06-00047-g005.jpg

相似文献

1
The Prevalence of Infection in the Adult Population of Russia: A Systematic Review and Meta-Analysis.俄罗斯成年人群感染率:系统评价与荟萃分析
Epidemiologia (Basel). 2025 Aug 12;6(3):47. doi: 10.3390/epidemiologia6030047.
2
Non-invasive diagnostic tests for Helicobacter pylori infection.幽门螺杆菌感染的非侵入性诊断测试。
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2.
3
[Trends in the prevalence of infection among adults in Moscow: a systematic review and meta-analysis].[莫斯科成年人感染率的趋势:系统评价与荟萃分析]
Ter Arkh. 2025 Jun 8;97(5):463-470. doi: 10.26442/00403660.2025.05.203250.
4
Optimum duration of regimens for Helicobacter pylori eradication.幽门螺杆菌根除治疗方案的最佳疗程
Cochrane Database Syst Rev. 2013 Dec 11;2013(12):CD008337. doi: 10.1002/14651858.CD008337.pub2.
5
Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.用于根除幽门螺杆菌的序贯疗法与标准三联一线疗法对比
Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD009034. doi: 10.1002/14651858.CD009034.pub2.
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
Eradication of for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCT.根除幽门螺杆菌预防65岁以上成年人阿司匹林相关消化性溃疡出血:HEAT随机对照试验
Health Technol Assess. 2025 Aug;29(42):1-62. doi: 10.3310/LLKF7871.
8
Tailored therapy guided by genotypic resistance from gastric mucosa samples in the first-line treatment of infection: a systematic review and meta-analysis.基于胃黏膜样本基因型耐药指导的一线治疗感染的个体化疗法:一项系统评价和荟萃分析。
Therap Adv Gastroenterol. 2025 Jun 26;18:17562848251348826. doi: 10.1177/17562848251348826. eCollection 2025.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.

本文引用的文献

1
[Trends in the prevalence of infection among adults in Moscow: a systematic review and meta-analysis].[莫斯科成年人感染率的趋势:系统评价与荟萃分析]
Ter Arkh. 2025 Jun 8;97(5):463-470. doi: 10.26442/00403660.2025.05.203250.
2
Antibiotic Resistance in Russia: A Systematic Review and Meta-Analysis.俄罗斯的抗生素耐药性:系统评价与荟萃分析
Antibiotics (Basel). 2025 May 19;14(5):524. doi: 10.3390/antibiotics14050524.
3
: Routes of Infection, Antimicrobial Resistance, and Alternative Therapies as a Means to Develop Infection Control.
感染途径、抗菌药物耐药性以及作为制定感染控制手段的替代疗法
Diseases. 2024 Dec 3;12(12):311. doi: 10.3390/diseases12120311.
4
AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review.美国胃癌高危个体筛查与监测的美国胃肠病学会临床实践更新:专家综述
Gastroenterology. 2025 Feb;168(2):405-416.e1. doi: 10.1053/j.gastro.2024.11.001. Epub 2024 Dec 23.
5
Prevalence of infection in China from 2014-2023: A systematic review and meta-analysis.2014-2023 年中国感染的流行情况:系统评价和荟萃分析。
World J Gastroenterol. 2024 Nov 21;30(43):4636-4656. doi: 10.3748/wjg.v30.i43.4636.
6
40 years after the discovery of Helicobacter pylori: towards elimination of H pylori for gastric cancer prevention.幽门螺杆菌发现40年后:迈向消除幽门螺杆菌以预防胃癌
Lancet. 2024 Jun 15;403(10444):2570-2572. doi: 10.1016/S0140-6736(24)01171-1.
7
A population-based study of Helicobacter pylori: Does asymptomatic infection mean no gastroscopic lesions?基于人群的幽门螺杆菌研究:无症状感染是否意味着无胃镜下病变?
Postgrad Med J. 2024 Feb 15;100(1181):179-186. doi: 10.1093/postmj/qgad119.
8
Standard Bismuth Quadruple Therapy versus Concomitant Therapy for the First-Line Treatment of Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.标准铋剂四联疗法与联合疗法用于感染一线治疗的比较:一项随机对照试验的系统评价和荟萃分析
J Clin Med. 2023 May 3;12(9):3258. doi: 10.3390/jcm12093258.
9
Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis.全球范围内 1980 年至 2022 年幽门螺杆菌感染的流行率:一项系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Jun;8(6):553-564. doi: 10.1016/S2468-1253(23)00070-5. Epub 2023 Apr 20.
10
Helicobacter pylori World Gastroenterology Organization Global Guideline.《幽门螺杆菌世界胃肠病学组织全球指南》
J Clin Gastroenterol. 2023 Feb 1;57(2):111-126. doi: 10.1097/MCG.0000000000001719.